Selling Pressure Seems to be cooling down
Chart seems to have bottomed out and now trading between MA(20) and MA(50)
Management seems to be scrambling to get votes in desperation
Outcome of Previous RS
Vanguard Increases Stake In Delcath Systems
As per new SEC filing Vanguard Increases Stake In Delcath Systems by 602% ahead of reverse split verdict
Three likely scenarios in September, Given buyout rumors and risk v/s reward ratio we recommend to hold a position in Declath as triggers ( FDA data , merger or buyout) favor a spike
Disclosure: I/we have no positions in any stocks mentioned, but may initiate a long position in DCTH over the next 72 hours.